WHO ICTRP trial
The effects of Caffeine on Attentional Networks
ACTRN12618000115235 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12618000115235 |
|---|---|
| Public title | The effects of Caffeine on Attentional Networks |
| Scientific title | The effects of Caffeine on Attentional Networks in Healthy Volunteers |
| Primary sponsor | University of Tasmania |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 4 |
| Countries | Australia |
| Conditions | Cognition (Attention); Cognition (Attention);Neurological - Studies of the normal brain and nervous system |
| Interventions | Acute (1 day) oral ingestion of 200mg Caffeine (2 x capsules) with a one-week washout period. Adherence monitored via direct observation by study staff. |
| Registration date | Jan 29, 2018 |
| Target size | 24 |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: